Home Compare GILD vs ORNBV.HE
Stock Comparison · Industry comparison · Drug Manufacturers - General

Gilead Sciences vs Orion Oyj: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with growth as the main driver and valuation adding further support. Gilead Sciences still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, with profitability adding a second layer of support. The overall score gap is 13 points in favour of Orion Oyj.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. GILD and ORNBV.HE share the same industry classification.

For a similarity-based comparison, see how Gilead Sciences and Orion Oyj each position within their functional peer groups in AssetNext.

Peer-Relative Score
GILD
Gilead Sciences, Inc.
70
Peer-Score
Signal qualityHigh
vs
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: GILD vs ORNBV.HE Profitability 79 100 Stability 65 71 Valuation 83 61 Growth 44 100 GILD ORNBV.HE
Gap Ranking
#1 Growth +56
#2 Valuation +22
#3 Profitability +21
#4 Stability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GILD and ORNBV.HE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GILDORNBV.HE Relative valuation Structural strength

The price setup looks more supportive for Orion Oyj, but Gilead Sciences, Inc. still has the stronger structure.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both profiles are strong on growth, but Orion Oyj leads clearly.
Valuation
On valuation, the same pattern holds: both are strong, but Gilead Sciences, Inc. still leads clearly.
Growth — Dominant Gap
GILD
44
ORNBV.HE
100
Gap+56in favour of ORNBV.HE

Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Gilead Sciences, with a forward P/E that is 2.3 turns lower there.

What this means for the comparison

Growth settles the comparison, while pricing and valuation keep the broader setup from looking fully aligned.

Explore full peer positioning in AssetNext

Break down the GILD vs ORNBV.HE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how GILD and ORNBV.HE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.